Share this video  

VJHemOnc is committed to improving our service to you

MPN Congress 2022 | Pursuing monoclonal antibodies for MPNs: targeting mutant calreticulin

Ann Mullally, MD, Dana-Farber Cancer Institute, Boston, MA, gives a presentation on targeting mutant calreticulin in myeloproliferative neoplasms (MPNs) at the 14th International Congress on Myeloproliferative Neoplasms (MPNs) held in New York City, NY.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter